Evidence map›Paper›PMID 12529855›Full record

ArticleAmerican journal of human genetics2003

FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation.

Elfride De Baere, Diane Beysen, Christine Oley, Birgit Lorenz, Julie Cocquet, Paul De Sutter, Koen Devriendt, Michael Dixon, Marc Fellous, Jean-Pierre Fryns and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 241 citations in OpenAlex.

  1. Modification of the Transcription Factor FOXL2 at Serines 101 and 107 Disables DNA Binding, Leads to Nucleolar Relocalization, and Rewires Granulosa-Cell Programs.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Functional analysis of 6 variations inSAGE open medicine · 2025
    Article
  8. Article
  9. NovelFrontiers in genetics · 2024
    Article
  10. Review
  11. Identification and functional analyses of a novelInternational journal of ophthalmology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. A Novel Missense Variant ofFrontiers in genetics · 2021
    Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 9 countries.

Elfride De BaereDepartment of Medical Genetics, Ghent University Hospital, Ghent, Belgium. Elfride.DeBaere@rug.ac.be
Diane Beysen
Christine Oley
Birgit Lorenz
Julie Cocquet
Paul De Sutter
Koen Devriendt
Michael Dixon
Marc Fellous
Jean-Pierre Fryns
Arturo Garza
Christoffer Jonsrud
Pasi A Koivisto
Amanda Krause
Bart P Leroy
Françoise Meire
Astrid Plomp
Lionel Van Maldergem
Anne De Paepe
Reiner Veitia
Ludwine Messiaen
Ghent University Hospital · BEInserm · FRInstitute of Pathology and Genetics · BENational Health Laboratory Service · ZARoyal Children's Hospital · AUTampere University Hospital · FIUniversity Hospital of North Norway · NOUniversity Hospital Regensburg · DEUniversity of Amsterdam · NLUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blepharophimosis syndrome (BPES), an autosomal dominant syndrome in which an eyelid malformation is associated (type I) or not (type II) with premature ovarian failure (POF), has recently been ascribed to mutations in FOXL2, a putative forkhead transcription factor gene. We previously reported 22 FOXL2 mutations and suggested a preliminary genotype-phenotype correlation. Here, we describe 21 new FOXL2 mutations (16 novel ones) through sequencing of open reading frame, 5' untranslated region, putative core promoter, and fluorescence in situ hybridization analysis. Our study shows the existence of two mutational hotspots: 30% of FOXL2 mutations lead to polyalanine (poly-Ala) expansions, and 13% are a novel out-of-frame duplication. In addition, this is the first study to demonstrate intra- and interfamilial phenotypic variability (both BPES types caused by the same mutation). Furthermore, the present study allows a revision of the current genotype-phenotype correlation, since we found exceptions to it. We assume that for predicted proteins with a truncation before the poly-Ala tract, the risk for development of POF is high. For mutations leading to a truncated or extended protein containing an intact forkhead and poly-Ala tract, no predictions are possible, since some of these mutations lead to both types of BPES, even within the same family. Poly-Ala expansions may lead to BPES type II. For missense mutations, no correlations can be made yet. Microdeletions are associated with mental retardation. We conclude that molecular testing may be carefully used as a predictor for POF risk in a limited number of mutations.

Indexed as

Genetic VariationGenotypePhenotype5' Untranslated RegionsBlepharophimosisChildChild, PreschoolDNA-Binding ProteinsFemaleForkhead Box Protein L2Forkhead Transcription FactorsGene DuplicationGenes, DominantHumansMaleMutation5' Untranslated RegionsDNA-Binding ProteinsForkhead Box Protein L2Forkhead Transcription FactorsFOXL2 protein, humanTranscription Factors

Identifiers

PMID12529855
PMCPMC379240
OpenAlexW2121875134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.